Inferior petrosal sinus ACTH and prolactin responses to CRH in ACTH-dependent Cushing's syndrome: a single centre experience from the United Kingdom.

Abstract:

:Inferior petrosal sinus sampling (IPSS) of ACTH with CRH stimulation helps distinguish pituitary ACTH-dependent Cushing's syndrome from the ectopic ACTH syndrome (EAS). The usefulness of the paradoxical response of other pituitary hormones including prolactin to CRH remains controversial. Data from 33 IPSS procedures carried out at the Walton Centre for Neurology and Neurosurgery in Liverpool were analyzed. Patients were selected for this procedure if they had been diagnosed with ACTH dependent Cushing's syndrome and the majority had no obvious pituitary adenoma on Magnetic Resonance Imaging. Satisfactory simultaneous bilateral catheterization was accomplished in 23/33 (success rate 70%). The diagnostic sensitivity of a basal central/peripheral ACTH ratio >2.0 and >3 post-CRH was 94%. In two patients with subsequently confirmed EAS the maximal central/peripheral ACTH ratio was <2.0 on basal samples and did not change following CRH. The maximal central/peripheral prolactin ratio was noted at 5 min post-CRH, coinciding with the maximal central/peripheral ACTH ratio. The intersinus gradient (ISG) of ACTH was paralleled by a consistent ISG of prolactin and in 7 out of 9 patients (with successful bilateral IPSS and unilateral adenomas) the ISG of prolactin correctly lateralized the microadenoma whereas the ISG of ACTH correctly lateralized in 8 out of 9 patients. Neither of the patients with EAS achieved a central/peripheral prolactin ratio >2 in the basal state and >3 post-CRH. Bilateral catheterization of inferior petrosal sinuses can be successful in up to 70% of cases. Prolactin measurements do not have superior lateralizing capability compared with ACTH but may be useful in the differential diagnosis of pituitary-driven from EAS.

journal_name

Pituitary

journal_title

Pituitary

authors

Daousi C,Nixon T,Javadpour M,Hayden K,MacFarlane IA

doi

10.1007/s11102-009-0200-4

subject

Has Abstract

pub_date

2010-06-01 00:00:00

pages

95-104

issue

2

eissn

1386-341X

issn

1573-7403

journal_volume

13

pub_type

杂志文章
  • Primary (autoimmune) hypophysitis: a single centre experience.

    abstract:BACKGROUND:Autoimmune hypophysitis (AH) is a rare autoimmune inflammatory disorder of pituitary gland. OBJECTIVE:To analyse clinical, hormonal, radiological features and management outcomes of AH. DESIGN:Retrospective analysis of patients with primary hypophysitis (where secondary causes of hypophysitis were ruled ou...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0550-9

    authors: Khare S,Jagtap VS,Budyal SR,Kasaliwal R,Kakade HR,Bukan A,Sankhe S,Lila AR,Bandgar T,Menon PS,Shah NS

    更新日期:2015-02-01 00:00:00

  • A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred.

    abstract::Familial neurohypophyseal diabetes insipidus (FNDI) is mostly an autosomal dominant inherited disorder presenting with severe polydipsia and polyuria typically in early childhood. To date, 69 different variations in the AVP gene encoding the AVP prohormone have been identified in autosomal dominant FNDI (adFNDI). In t...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0392-x

    authors: Birkegaard C,Christensen JH,Falorni A,Marzotti S,Minarelli V,Gregersen N,Rittig S

    更新日期:2013-06-01 00:00:00

  • Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center.

    abstract:PURPOSE:Long-acting somatostatin analogs are one of the main classes of medical therapy used for acromegaly and most patients require ongoing treatment. Few studies have evaluated the long-term efficacy and safety of lanreotide depot beyond 2 years. The goal of this study was to provide a long-term longitudinal assessm...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-016-0724-3

    authors: Sagvand BT,Khairi S,Haghshenas A,Swearingen B,Tritos NA,Miller KK,Klibanski A,Nachtigall LB

    更新日期:2016-08-01 00:00:00

  • Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly.

    abstract::Most patients with acromegaly have some degree of insulin resistance. The principal mediator of insulin resistance in acromegaly is hypersecretion of growth hormone. Growth hormone acts at several levels to block insulin actions including inhibiting phosphorylation of the insulin receptor and one of its principal sign...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1023321421760

    authors: Clemmons DR

    更新日期:2002-01-01 00:00:00

  • Overview of vascular complications of pituitary surgery with special emphasis on unexpected abnormality.

    abstract::Arterial bleeding during transsphenoidal surgery for pituitary adenoma is known complication. This usually happens due to rupture of intracavernous carotid or delayed hemorrhage due to the carotico-cavernous fistula and/or pseudoaneurysm. There is also evidence that cavernous carotid aneurysms may occur with pituitary...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-009-0198-7

    authors: Berker M,Aghayev K,Saatci I,Palaoğlu S,Onerci M

    更新日期:2010-06-01 00:00:00

  • Sellar collision tumor involving pituitary gonadotroph adenoma and chondroma: a potential clinical diagnosis.

    abstract::We report on a 74-year-old male patient who presented with progressive neuroophthalmologic symptoms soon after the administration of a long-acting gonadotropin-releasing hormone agonist for treatment of a prostate cancer. Imaging revealed a destructively growing and extensively calcified sellar mass inconsistent with ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-009-0199-6

    authors: Sahli R,Christ E,Kuhlen D,Giger O,Vajtai I

    更新日期:2011-12-01 00:00:00

  • Proliferation markers in different types of clinically non-secreting pituitary adenomas.

    abstract::160 clinically non-secreting pituitary adenomas were examined in regard to their expression of the markers PCNA, bcl2, Ki 67 in the mib-1 modification and p53 which are still under investigation for their relevance to cell proliferation. The series contained 60 null cell adenomas, 60 oncocytomas and 40 gonadotroph ade...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1009933820856

    authors: Schreiber S,Saeger W,Lüdecke DK

    更新日期:1999-05-01 00:00:00

  • The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

    abstract::The metabolic consequences of thyroxine replacement in patients with central hypothyroidism (CH) need to be evaluated. The aim was to examine the outcome of thyroxine replacement in CH. Adult hypopituitary patients (n = 1595) with and without CH from KIMS (Pfizer International Metabolic Database) were studied before a...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-011-0356-6

    authors: Filipsson Nyström H,Feldt-Rasmussen U,Kourides I,Popovic V,Koltowska-Häggström M,Jonsson B,Johannsson G

    更新日期:2012-12-01 00:00:00

  • Primary central nervous system lymphoma mimicking pituitary apoplexy: case report.

    abstract::Lymphoma involving the pituitary gland is very rare and usually results from metastatic spread of systemic lymphoma. We present a case of primary central nervous system (CNS) large B cell lymphoma that manifested as pituitary apoplexy. A 45-year-old woman presented with headache, and then rapidly developed a third ner...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-008-0084-8

    authors: Quintero Wolfe S,Hood B,Barker J,Benveniste RJ

    更新日期:2009-01-01 00:00:00

  • IGF-I assays: current assay methodologies and their limitations.

    abstract::The diagnosis of disorders of growth hormone (GH) is dependent upon accurate measurement of insulin-like growth factor-I (IGF-I) concentrations since serum IGF-I assays have been found to be useful as a screening tests for the presence of growth hormone deficiency (GHD) in children and in both children and adults they...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-007-0032-z

    authors: Clemmons DR

    更新日期:2007-01-01 00:00:00

  • Pituitary lymphoma: a case report and literature review.

    abstract::We report the case of a B-cell type pituitary lymphoma in a 65 year-old male immunocompetent patient who presented with hypogonadotropic hypogonadism and central hypothyroidism and subsequently developed pulmonary lymphoma. Only three cases of pituitary lymphoma have been previously reported, one in a patient with acq...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1009969417380

    authors: Mathiasen RA,Jarrahy R,Cha ST,Kovacs K,Herman VS,Ginsberg E,Shahinian HK

    更新日期:2000-05-01 00:00:00

  • Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis.

    abstract::Primary autoimmune hypophysitis (PAH) is considered an underdiagnosed disease, due to the difficulty in reaching a definitive diagnosis. PAH clinical diagnosis remains an exclusion diagnosis. We aimed to correlate PAH neuro-radiological signs to endocrine features and evaluate their prognostic role. 24 PAH cases were ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-018-0892-4

    authors: Tartaglione T,Chiloiro S,Laino ME,Giampietro A,Gaudino S,Zoli A,Bianchi A,Pontecorvi A,Colosimo C,De Marinis L

    更新日期:2018-08-01 00:00:00

  • The relationship between prolactin (PRL), leptin, nitric oxide (NO), and cytokines in patients with hyperprolactinemia.

    abstract::Leptin is a key mediator in the maintenance of neuroendocrine homeostasis. The aim of this study was to determine the changes in serum leptin, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), nitric oxide (NO) levels in patients with hyperprolactinemia. The study consists of 16 consecutive patients with ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-008-0140-4

    authors: Balci H,Akgun-Dar K,Gazioglu N,Kapucu A,Bolayirli M,Oz B

    更新日期:2009-01-01 00:00:00

  • "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.

    abstract:PURPOSE:Approximately 25 % of cases of clinically active acromegaly cases treated in our academic center between 1996 and 2000, were diagnosed in patients who had elevated plasma IGF-1 levels, but apparently "normal" 24-h mean plasma GH levels. The current study served to update the data for patients with acromegaly re...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-016-0735-0

    authors: Butz LB,Sullivan SE,Chandler WF,Barkan AL

    更新日期:2016-12-01 00:00:00

  • Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma.

    abstract::In this report we emphasize the opportunity of considering the uncommon causes of chronic GH-excess in the initial diagnostic process, such as GHRH hypersecretion, especially in the presence of ambiguous pituitary neuroimaging. This topic may have an important clinical significance in order to plan the most cost-effec...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-008-0146-y

    authors: Verrua E,Ronchi CL,Ferrante E,Ferrari DI,Bergamaschi S,Ferrero S,Zatelli MC,Branca V,Spada A,Beck-Peccoz P,Lania AG

    更新日期:2010-09-01 00:00:00

  • Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview.

    abstract:BACKGROUND:The growing interest in the molecular and genetic alterations of craniopharyngiomas (CPs) is embodied in recent studies revealing insights into the CP tumorigenesis and identifying novel molecular pathways amenable of targeted therapies. The actual impact of this new information, however, remains inconclusiv...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-018-0890-6

    authors: Prieto R,Pascual JM

    更新日期:2018-08-01 00:00:00

  • Epidemiology of acromegaly.

    abstract::Acromegaly is a consequence of chronic growth hormone (GH) excess, due in the majority of cases to a GH-secreting pituitary adenoma, and occurring with a population prevalence of 60 per million and an incidence of 3-4 per million per year. Males and females appear to be equally affected with an average age of presenta...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1009965803750

    authors: Holdaway IM,Rajasoorya C

    更新日期:1999-06-01 00:00:00

  • Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?

    abstract::Cushing's Syndrome (CS) is associated with an increased mortality, where hypercoagulability seems to have a crucial role in both arterial and venous thrombosis. Parameters of in vitro thrombin generation (TG) such as lag time, peak thrombin and endogenous thrombin potential (ETP), that describe the time until thrombin...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0467-3

    authors: Koutroumpi S,Spiezia L,Albiger N,Barbot M,Bon M,Maggiolo S,Gavasso S,Simioni P,Frigo A,Mantero F,Scaroni C

    更新日期:2014-02-01 00:00:00

  • Craniopharyngioma surgery.

    abstract::Ideal surgical treatment of craniopharyngiomas remains a major challenge for neurosurgeons. Craniopharyngiomas grow in the deep-seated hypothalamic area that is paramount for vegetative, emotional and endocrine function, and for maintaining worthwhile life. The benign histological nature of craniopharyngiomas belies t...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-008-0137-z

    authors: Honegger J,Tatagiba M

    更新日期:2008-01-01 00:00:00

  • Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.

    abstract::We report the case of a 60 year old male who complained of headache and blurry vision--that progressed to left ophthalmoplegia and ptosis--after receiving a dose of leuprolide for Prostate cancer therapy. Imaging showed a hemorrhagic sellar mass. The patient underwent transsphenoidal debulking, and the tissue obtained...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-009-0202-2

    authors: Guerra Y,Lacuesta E,Marquez F,Raksin PB,Utset M,Fogelfeld L

    更新日期:2010-01-01 00:00:00

  • The effect of somatostatin analogs and acromegaly on the upper gastrointestinal system.

    abstract:PURPOSE:To evaluate the effects of somatostatin analogs and disease activity status on the upper gastrointestinal system in patients with acromegaly. METHODS:One hundred eighty-one patients with acromegaly were retrospectively assessed. The demographic, biochemical, pathologic, and radiologic data of the patients were...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-020-01095-3

    authors: Sahin S,Icli TB,Durcan E,Sulu C,Ozkaya HM,Hatemi AI,Kadioglu P

    更新日期:2020-10-19 00:00:00

  • Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.

    abstract::Nonfunctioning pituitary adenomas (NFPA) are typically benign neoplasms that can cause significant morbidity through local mass effects. MIB-1/Ki-67 and p53 immuno-reactivity are used to predict aggressive behavior but have known limitations. No marker to date is widely used to reliably predict tumor progression. Phos...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-011-0367-3

    authors: Hightower E,Cabanillas ME,Fuller GN,McCutcheon IE,Hess KR,Shah K,Waguespack SG,Corley LJ,Devin JK

    更新日期:2012-12-01 00:00:00

  • Clinical picture and the treatment of TBI-induced hypopituitarism.

    abstract::Traumatic brain injury (TBI) is an important public health problem with an increasing incidence in the last years. Relatively few cases are fatal; most individuals will survive and, in the long-term, the sequalae of TBI will include neuroendocrine dysfunctions with a much higher frequency than previously suspected. Pa...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-019-00956-w

    authors: Caputo M,Mele C,Prodam F,Marzullo P,Aimaretti G

    更新日期:2019-06-01 00:00:00

  • Medical combination therapies in Cushing's disease.

    abstract:INTRODUCTION:There has been growing interest on medical therapy for the management of Cushing's disease (CD), particularly in cases of persistent or recurrent hypercortisolism. Ketoconazole, an inhibitor of adrenal steroidogenesis, is the most widely used drug, whereas cabergoline and pasireotide are the most promising...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-015-0641-x

    authors: Vilar L,Naves LA,Machado MC,Bronstein MD

    更新日期:2015-04-01 00:00:00

  • Twelve cases of pituitary metastasis: a case series and review of the literature.

    abstract:PURPOSE:The pituitary gland is an unusual site for metastatic spread, but as patients with metastatic malignancy are living longer, it may become more prevalent. Compression of important anatomy adjacent to the sella may produce disabling symptoms and endocrine derangement, leading to significant morbidity. METHODS:An...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-018-0899-x

    authors: Castle-Kirszbaum M,Goldschlager T,Ho B,Wang YY,King J

    更新日期:2018-10-01 00:00:00

  • What are critical outcome measures for patients receiving pituitary replacement following brain injury?

    abstract::There are scant prospective studies defining improvements in critical outcome measures with hormone replacement in hypopituitarism secondary to brain injury. We review the tests of cognition and physical function and summarize their use for subjects that are deficient in anterior hormone production during anterior pit...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-008-0133-3

    authors: Beca SG,High WM Jr,Masel BE,Mossberg KA,Urban RJ

    更新日期:2012-03-01 00:00:00

  • Mechanism of action of octreotide in acromegalic tumours in vivo using dynamic contrast-enhanced magnetic resonance imaging.

    abstract:CONTEXT:Octreotide causes significant tumour shrinkage in patients with acromegaly but the exact mechanism of action is unclear in vivo. OBJECTIVE:To determine the mechanism of action of octreotide in vivo using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). DESIGN:Five patients with acromegaly were ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-007-0044-8

    authors: Sathyapalan T,Lowry M,Turnbull LW,Rowland-Hill C,Atkin SL

    更新日期:2007-01-01 00:00:00

  • Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience.

    abstract::Acromegaly is associated with serious morbidity and mortality, if not well controlled. Approved somatostatin receptor ligands (SRLs) are a mainstay of medical therapy and exhibit preferential affinity for somatostatin receptor (SSTR) subtype 2. Our objective was to assess whether characteristic features of individual ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0445-1

    authors: Brzana J,Yedinak CG,Gultekin SH,Delashaw JB,Fleseriu M

    更新日期:2013-12-01 00:00:00

  • Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?

    abstract:INTRODUCTION:Early disease onset, clinical manifestation, histomorphology, and increased tendency to relapse distinguish the adamantinomatous craniopharyngioma (adaCP) from the more favorable papillary variant (papCP). A molecular hallmark of adaCP is the activated Wnt signaling pathway indicated by nuclear β-catenin a...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0543-8

    authors: Hölsken A,Stache C,Schlaffer SM,Flitsch J,Fahlbusch R,Buchfelder M,Buslei R

    更新日期:2014-12-01 00:00:00

  • Silent somatotroph pituitary adenomas: an update.

    abstract::Silent growth hormone adenomas (SGHA) are a rare entity of non-functioning pituitary neuroendocrine tumors. Diagnosis is invariably made post-operatively of a tumor immunopositive for GH (and Pit-1 in selected cases) but without clinical acromegaly. Mainly young females are affected, and tumors are often uncovered by ...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-017-0858-y

    authors: Langlois F,Woltjer R,Cetas JS,Fleseriu M

    更新日期:2018-04-01 00:00:00